Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Mucoviscidosis: CFTR mutation-specific therapy: a ray of sunshine in a cloudy sky].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie - 1 Jan 2013

Leonard A, Leal T, Lebecque P

Abstract excerpt

There is a need to find a cure for pulmonary disease in cystic fibrosis (CF), though full benefit of this approach will be restricted to those patients with well-preserved lungs. The most promising route is currently that of a pharmacological mutation-specific approach aiming at correcting the me...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chlorides
Share to Cystic Fibrosis
Share to Cystic Fibrosis Transmembrane Conductance Regulator

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epithelial Cells

Share to Evidence-Based Medicine

Share to Mutation

Share to Treatment Outcome

Source

Identifiers

PMID: 23199563
DOI: 10.1016/j.arcped.2012.10.018

Genes

CFTR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23199563-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Mucoviscidosis: CFTR mutation-specific therapy: a ray of sunshine in a cloudy sky].PMID 23199563Read ↗

Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.Semantic proximity Read ↗

[Evidence-based treatment of cystic fibrosis].Semantic proximity Read ↗

Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination.Semantic proximity Read ↗

Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation.Semantic proximity Read ↗

Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation.Semantic proximity Read ↗

Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice.Semantic proximity Read ↗

The behaviour of the cystic fibrosis respiratory epithelium and its response to multidose CFTR gene therapySemantic proximity Read ↗

A CFTR potentiator in patients with cystic fibrosis and the G551D mutation.Semantic proximity Read ↗

[CFTR and cystic fibrosis, a 50-year long history].Semantic proximity Read ↗

Molecular dynamics and theratyping in airway and gut organoids reveal R352Q-CFTR conductance defectSemantic proximity Read ↗

Chloride Conductance, Nasal Potential Difference and Cystic Fibrosis Pathophysiology.Semantic proximity Read ↗

[Mucoviscidosis/cystic fibrosis (CF)].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.